Filament Health Is the First Public Company to be Issued a Patent for Extraction of Natural Psilocybin
Since natural psilocybin is typically expensive to extract, most companies create synthetic psilocybin, but not Filament Health (FH).
The Vancouver-based company developed an innovative technology that extracts and standardizes natural psilocybin to overcome crop-to-crop and flush-to-flush variability at a low cost. On Tuesday, Filament received a patent for the process, making it the first publicly traded company to receive a patent from the Canadian Intellectual Property Office for the extraction of natural psilocybin.